The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

LGP by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: IT stocks lead index higher | January 22, 2025

This was a seven-week closing high, achieved amidst positive sentiment as investors react to Donald Trump’s…
All watched over by machines of loving grace is a pretty good documentary

Wednesday notes: NEXTDC jumps on Trump’s $500B AI spend plan; JB Hi-Fi hits new record

It was a day not without its big-name earnings from the likes of Bubs (ASX:BUB) and
Home being built construction dwelling labour

200k new housing starts in 2026: UBS sees upside for construction, but are home prices too high?

In a new Global Research note from a team of UBS analysts headed by Economist George Tharenou, UBS sees “upside risk” for the
Image representing wireless networks

Etherstack signs US$1.2M deal with telecom giant AT&T, shares jump 12%

Etherstack Plc has signed a US$1.2M contract with global telecommunications carrier giant AT&T, pushing its shares…